Cargando…
Vancomycin dosing in an obese patient with acute renal failure: A case report and review of literature
BACKGROUND: Vancomycin is the most commonly used drug for methicillin-resistant Staphylococcus aureus. The empirical clinical doses of vancomycin based on non-obese patients may not be optimal for obese ones. CASE SUMMARY: This study reports a case of vancomycin dosing adjustment in an obese patient...
Autores principales: | Xu, Kun-Yan, Li, Dan, Hu, Zhen-Jie, Zhao, Cong-Cong, Bai, Jing, Du, Wen-Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254177/ https://www.ncbi.nlm.nih.gov/pubmed/35949852 http://dx.doi.org/10.12998/wjcc.v10.i18.6218 |
Ejemplares similares
-
Vancomycin: Acute renal failure: case report
Publicado: (2021) -
393 Vancomycin Dosing in Obese Patients
por: Alquwaizani, Mohammed, et al.
Publicado: (2014) -
An Evaluation of Systemic Vancomycin Dosing in Obese Patients
por: Kubiak, David W., et al.
Publicado: (2015) -
Vancomycin-Induced Leukocytoclastic Vasculitis and Acute Renal Failure Due to Tubulointerstitial Nephritis
por: Pingili, Chandra Shekar, et al.
Publicado: (2017) -
Vancomycin: Acute kidney failure: case report
Publicado: (2021)